Insider Transactions in Q4 2022 at Regeneron Pharmaceuticals, Inc. (REGN)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 31
2022
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,518
-4.94%
|
$1,140,018
$751.24 P/Share
|
|
Oct 31
2022
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+6.11%
|
$762,000
$381.92 P/Share
|
|
Oct 26
2022
|
Christopher R. Fenimore VP Controller |
BUY
Bona fide gift
|
Indirect |
871
+48.6%
|
-
|
|
Oct 26
2022
|
Christopher R. Fenimore VP Controller |
SELL
Bona fide gift
|
Indirect |
871
-100.0%
|
-
|
|
Oct 17
2022
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
358
-1.23%
|
$264,562
$739.5 P/Share
|
|
Oct 14
2022
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,142
-3.78%
|
$848,506
$743.78 P/Share
|
|
Oct 14
2022
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,500
+4.73%
|
$571,500
$381.92 P/Share
|
|
Oct 05
2022
|
Christopher R. Fenimore VP Controller |
SELL
Open market or private sale
|
Direct |
1,844
-10.09%
|
$1,381,156
$749.0 P/Share
|
|
Oct 03
2022
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Indirect |
304
-0.24%
|
-
|
|
Oct 03
2022
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.04%
|
$72,100
$721.63 P/Share
|
|
Oct 03
2022
|
Craig B. Thompson Director |
BUY
Grant, award, or other acquisition
|
Direct |
279
+50.0%
|
-
|
|
Oct 03
2022
|
Marion Mc Court EVP Commercial |
SELL
Open market or private sale
|
Direct |
1,100
-2.72%
|
$775,500
$705.39 P/Share
|
|
Oct 03
2022
|
Marion Mc Court EVP Commercial |
BUY
Exercise of conversion of derivative security
|
Direct |
1,100
+2.65%
|
$392,700
$357.69 P/Share
|
|
Oct 03
2022
|
Christopher R. Fenimore VP Controller |
SELL
Open market or private sale
|
Direct |
3,346
-15.48%
|
$2,422,504
$724.0 P/Share
|
|
Oct 03
2022
|
Marc Tessier Lavigne Director |
SELL
Open market or private sale
|
Direct |
3,612
-61.42%
|
$2,593,416
$718.0 P/Share
|
|
Oct 03
2022
|
Marc Tessier Lavigne Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,612
+38.05%
|
$1,491,756
$413.33 P/Share
|